Home › Funds › LuminArx Capital Management LP › BCTX
LuminArx Capital Management LP position in BCTX
BRIACELL THERAPEUTICS CORP · Health Care
LuminArx Capital Management LP reported holding 25,000 shares of BCTX (BRIACELL THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$29K, representing 0.04% of its reported portfolio and ranking #45 among its reported holdings. LuminArx Capital Management LP has disclosed BCTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How LuminArx Capital Management LP's BCTX position evolved
LuminArx Capital Management LP first disclosed a stake in BCTX in Q1 2026 at 15,000 shares (US$63K). Across 3 filings, LuminArx Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 25,000 shares valued at US$29K. Notable position changes include a 67% increase in Q2 2026 (shares rose 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 15.00K | $62.85K | New |
| Q2 2026 | 25.00K | $22.25K | Add |
| Q3 2026 | 25.00K | $29.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCTX and 13F data
BCTX (BRIACELL THERAPEUTICS CORP) is a Health Care company. 17 other funds we track also report a position in BCTX — the largest reported positions include IRIDIAN ASSET MANAGEMENT LLC/CT (US$278K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCTX
- IRIDIAN ASSET MANAGEMENT LLC/CT 65.00K sh · $278.20K · Q3 2026
More on LuminArx Capital Management LP
FAQ
How long has LuminArx Capital Management LP held BCTX?
LuminArx Capital Management LP has disclosed BCTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is LuminArx Capital Management LP's current position in BCTX?
As of Q3 2026, LuminArx Capital Management LP holds 25.00K shares of BCTX (BRIACELL THERAPEUTICS CORP), valued at $29.00K, representing 0.04% of its reported portfolio and ranking #45.
Has LuminArx Capital Management LP been buying or selling BCTX?
In the latest 13F filing (Q3 2026), LuminArx Capital Management LP held unchanged its position in BCTX.
Which other funds hold BCTX?
Other major institutional holders of BCTX include IRIDIAN ASSET MANAGEMENT LLC/CT, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.